{
  "docId": "019de073-bcea-715e-8f3b-2af68c1e6615",
  "docSlug": "cfcb19cc2b89b85461a28b4631a8b033",
  "documentTitle": "Hepion Pharmaceuticals | Results Presentation Deck | 34 slides",
  "authorId": "hepion-pharmaceuticals",
  "authorName": "Hepion Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 32,
  "pageCount": 34,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Slide 32 of the deck.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bcea-715e-8f3b-2af68c1e6615/32",
  "deckHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615",
  "deckJsonHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615.json",
  "deckAnchorHref": "/decks/019de073-bcea-715e-8f3b-2af68c1e6615#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.55,
        "y": 0.05
      },
      "kind": "diagram",
      "text": "Two Value Drivers: Rencofilstat and AI-POWR",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5731dc9a-82fc-41bf-90b4-9cca361bd8c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "Rencofilstat, once-daily oral, targeting key drivers of pathology, tested in over 200 subjects. Two Phase 2 NASH trials underway. Upcoming Phase 2 for HCC. Developing companion A.I. Core scientific team developed voclosporin. Robust IP.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "205aa8ef-69b5-486f-912d-1fff0433e0c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.75,
        "y": 0.65
      },
      "kind": "metric",
      "text": "76.2 M Common Shares Outstanding",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0dd9df1b-5017-4d98-9bec-fd800d211702",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.55,
        "y": 0.65
      },
      "kind": "metric",
      "text": "$71.7 M Cash as of 6/30/22",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "805e6523-9167-4e24-9289-2726949364ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Tackling Fibrotic Diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8320c562-b317-4e88-9877-f6cac17f36d3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "d4112a1c-c738-4613-9460-b9c2bbbed54b",
      "evidence": "The slide provides a high-level overview of Hepion's approach, including key points and metrics, typical of an executive summary.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}